Efficacy of psychoeducation in the treatment of unipolar depression

ISRCTN ISRCTN10760801
DOI https://doi.org/10.1186/ISRCTN10760801
Secondary identifying numbers N/A
Submission date
20/04/2009
Registration date
30/04/2009
Last edited
30/04/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Alma Dzubur Kulenovic
Scientific

Bolnicka 25
Sarajevo
71000
Bosnia and Herzegovina

Phone +387 (0)61 223 708
Email almadz@epn.ba

Study information

Study designInterventional opened multicentric randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Only available to recruiting centres
Scientific titleEfficacy of psychoeducation in the treatment of unipolar depression: a multicentric randomised controlled trial
Study objectivesPsychoeducation combined with treatment as usual leads to a greater reduction in depressive symptoms as measured by the Beck Depression Inventory (BDI) and Hamilton Depression Scale (HAM-D), and greater increase of subjective perception of the quality of life as measured by the Manchester Quality of Life Scale (MANSA) in subjects diagnosed with unipolar depression, than treatment as usual alone.
Ethics approval(s)University Clinical Centre of Sarajevo Ethics Committee approved on the 21st March 2008
Health condition(s) or problem(s) studiedUnipolar depression in adults
InterventionThe subjects in the experimental group will receive an 8-week course on psychoeducation based on Lewinsohn's Coping With Depression Course combined with treatment as usual (TAU). The subjects in the control group will receive TAU only.

Assessments will be made with the use of standardised psychometric instruments:
1. International Neuropsychiatric Interview (MINI 5.00)
2. Mini Mental State Exam (MMSE)
3. Beck Depression Inventory (BDI)
4. Hamilton Depression Scale (HAM-D)
5. Manchester Quality of Life Scale (MANSA)
6. Socio-demographic questionnaire (specially designed for this study)

Assessments will be performed before the intervention, after the intervention and in 6 and 12 months follow-up. The study will adhere with the methodology of a randomised controlled trial.
Intervention typeOther
Primary outcome measureTo assess possible changes in the total score on Beck Depression Inventory scale (BDI), and Hamilton Depression Scale (HAM-D), between the subjects who received psychoeducation and treatment as usual and the subjects who received only treatment as usual, after a 12 week course of psychoeducation, and in 9 months follow-up.
Secondary outcome measures1. To assess possible changes in the total score on Manchester Quality of Life Scale (MANSA) between the subjects who received psychoeducation and treatment as usual and the subjects who received only treatment as usual, after a 12 week course of psychoeducation and in 9 months follow-up
2. To assess possible differences in types of mental health services received between the two groups in 9 months follow-up
Overall study start date01/05/2009
Completion date01/05/2010

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants120
Key inclusion criteria1. Adult subjects aged 18 to 65 years, either sex
2. Diagnosis of unipolar depression (F 32.0-2, F 33.0-2)
3. Not due to a medical condition (Diagnostic and Statistical Manual of Mental Disorders, 4th Edition [DSM IV] Axis V = 0)
4. No other Axis I co-morbid psychiatric disorder
5. Duration of symptoms not less than 3 months
6. Able to read and write (8 years formal education)
7. Subjects who sign the informed consent to participate in the study
Key exclusion criteria1. Refused to sign informed consent
2. Illiterate
3. Deaf or hearing impaired
4. Serious speech impairment or mutisim
5. Duration of symptoms less than three months
6. Symptoms of psychotic depression
7. History of a manic or hypo-manic episode
8. Cognitive impairment (mini Mental State Examination [MMSE] greater than or equal to 25)
9. Co-morbid anxiety disorder
10. Organic affective disorder
11. Depression caused by an underlying medical condition
12. Co-morbid personality disorder
13. Alcohol and preliminary alcohol screening (PAS) abuse and dependence
14. Subjects who are currently involved in other research
15. Pregnancy
16. Epilepsy
17. Subjects whose present condition requires psychiatric hospitalisation
18. Suicidality
Date of first enrolment01/05/2009
Date of final enrolment01/05/2010

Locations

Countries of recruitment

  • Bosnia and Herzegovina

Study participating centre

Bolnicka 25
Sarajevo
71000
Bosnia and Herzegovina

Sponsor information

Clinical Centre University of Sarajevo (Bosnia and Herzegovina)
Hospital/treatment centre

Psychiatric Clinic
Bolnicka 25
Sarajevo
71000
Bosnia and Herzegovina

Phone +387 (0)61 223 708
Email psihijatrija@bih.net.ba
ROR logo "ROR" https://ror.org/019bz1656

Funders

Funder type

Government

European Union (EU) (Belgium) - Sixth Framework Programme (FP6): EVIDENCE (Strengthening Research Capacities and Evaluation of Mental Health Services in Bosnia and Herzegovina) (grant ref: INCO-CT-2007-043654 FP6)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan